Fisher Asset Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Fisher Asset Management's RCUS Position: Q3 2026 in Review
Fisher Asset Management reduced its Arcus Biosciences (RCUS) stake by 10% in Q3 2026, selling an estimated $6.23M and leaving 1,918,497 shares worth $49.6M. The position accounts for 0.01% of the portfolio, ranked #233.
Fisher Asset Management first reported a position in RCUS in Q1 2025 and has held it in 7 quarters since. The position peaked at $66M in Q2 2026. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Fisher Asset Management held 1,918,497 shares of Arcus Biosciences worth $49.6M as of Q3 2026.
- Fisher Asset Management sold 220,899 Arcus Biosciences shares in Q3 2026, an estimated $6.23M.
- Arcus Biosciences made up 0.01% of Fisher Asset Management's portfolio in Q3 2026, its #233 holding.
- Fisher Asset Management first reported a position in Arcus Biosciences in Q1 2025 and has held it in 7 quarters since.
- Fisher Asset Management's Arcus Biosciences position peaked at $66M in Q2 2026.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Fisher Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.